{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:49:35Z","timestamp":1769824175733,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00259-018-4155-4","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T06:12:59Z","timestamp":1537078379000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["FDG PET in response evaluation of bulky masses in paediatric Hodgkin\u2019s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial"],"prefix":"10.1007","volume":"46","author":[{"name":"AIEOP Hodgkin Lymphoma Study Group, Italy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"Egesta","family":"Lopci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Mascarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Castello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Borsatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Todesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Zucchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Farruggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Cistaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Buffardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Moleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feisal","family":"Bunkheila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Burnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"key":"4155_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00259-006-0253-9","volume":"34","author":"Z Bar-Sever","year":"2007","unstructured":"Bar-Sever Z, Keidar Z, Ben-Barak A, Bar-Shalom R, Postovsky S, Guralnik L, et al. The incremental value of 18F-FDG PET\/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging. 2007;34:630\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4155_CR2","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2967\/jnumed.107.044628","volume":"48","author":"M Tatsumi","year":"2007","unstructured":"Tatsumi M, Miller JH, Wahl RL. 18F-FDG PET\/CT in evaluating non-CNS pediatric malignancies. J Nucl Med. 2007;48:1923\u201331.","journal-title":"J Nucl Med"},{"key":"4155_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.semnuclmed.2007.04.001","volume":"37","author":"H Jadvar","year":"2007","unstructured":"Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PET and PET\/CT in pediatric oncology. Semin Nucl Med. 2007;37:316\u201331.","journal-title":"Semin Nucl Med"},{"key":"4155_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/pbc.20797","volume":"48","author":"HJ Meany","year":"2007","unstructured":"Meany HJ, Gidvani VK, Minniti CP. Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer. 2007;48:399\u2013402.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"4155_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/cbr.2008.0519","volume":"23","author":"E Lopci","year":"2008","unstructured":"Lopci E, Burnelli R, Ambrosini V, Nanni C, Castellucci P, Biassoni L, et al. (18)F-FDG PET in pediatric lymphomas: a comparison with conventional imaging. Cancer Biother Radiopharm. 2008;23(6):681\u201390.","journal-title":"Cancer Biother Radiopharm"},{"key":"4155_CR6","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res. 1971;31:1860\u20131.","journal-title":"Cancer Res"},{"key":"4155_CR7","first-page":"137","volume-title":"Cancer in children. Clinical management","author":"O Oberlin","year":"1998","unstructured":"Oberlin O. Hodgkin\u2019s disease. In: Vo\u00fbte PA, Kalifa C, Barrett A, editors. Cancer in children. Clinical management. 4th ed. New York: Oxford University; 1998. p. 137\u201353.","edition":"4"},{"key":"4155_CR8","first-page":"413","volume-title":"Manual of pediatric hematology and oncology","author":"P Lanzkowski","year":"1999","unstructured":"Lanzkowski P. Hodgkin\u2019s disease. In: Lanzkowski P, editor. Manual of pediatric hematology and oncology. 3rd ed. San Diego: Academic; 1999. p. 413\u201343.","edition":"3"},{"key":"4155_CR9","first-page":"313","volume":"36","author":"MM Hudson","year":"1999","unstructured":"Hudson MM, Donaldson SS. Treatment of pediatric Hodgkin\u2019s lymphoma. Semin Hematol. 1999;36:313\u201323.","journal-title":"Semin Hematol"},{"issue":"32","key":"4155_CR10","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","volume":"32","author":"Debra L. Friedman","year":"2014","unstructured":"Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031. J Clin Oncol. 2014;32:3651\u20138.","journal-title":"Journal of Clinical Oncology"},{"issue":"26","key":"4155_CR11","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","volume":"27","author":"C Furth","year":"2009","unstructured":"Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Sch\u00f6nberger S, et al. Early and late therapy response assessment with [18F] fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial. J Clin Oncol. 2009;27(26):4385\u201391.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4155_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.116.176511","volume":"58","author":"S Bakhshi","year":"2017","unstructured":"Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al. Posttreatment PET\/CT rather than interim PET\/CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma: a prospective study comparing PET\/CT with conventional imaging. J Nucl Med. 2017;58(4):577\u201383.","journal-title":"J Nucl Med"},{"key":"4155_CR13","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s002590000340","volume":"27","author":"L Kostakoglu","year":"2000","unstructured":"Kostakoglu L, Goldsmith SJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med. 2000;27:1564\u201378.","journal-title":"Eur J Nucl Med"},{"key":"4155_CR14","first-page":"1139","volume":"42","author":"H Sch\u00f6der","year":"2001","unstructured":"Sch\u00f6der H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, et al. Effect of whole-body (18)FFDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med. 2001;42:1139\u201343.","journal-title":"J Nucl Med"},{"key":"4155_CR15","first-page":"343","volume":"38","author":"CK Hoh","year":"1997","unstructured":"Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, et al. Whole-body FDG-PET imaging for staging of Hodgkin\u2019s disease and lymphoma. J Nucl Med. 1997;38:343\u20138.","journal-title":"J Nucl Med"},{"key":"4155_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1040-8428(01)00127-5","volume":"38","author":"JN Talbot","year":"2001","unstructured":"Talbot JN, Haioun C, Rain JD, Meignan M, Wioland M, Misset JL, et al. [18F]-FDG positron imaging in clinical management of lymphoma patients. Crit Rev Oncol Hematol. 2001;38:193\u2013221.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4155_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1097-0142(20010115)91:2<302::AID-CNCR1002>3.0.CO;2-4","volume":"91","author":"B Hueltenschmidt","year":"2001","unstructured":"Hueltenschmidt B, Sautter-Bihl ML, Lang O, Maul FD, Fischer J, Mergenthaler HG, et al. Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer. 2001;91:302\u201310.","journal-title":"Cancer"},{"key":"4155_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","volume":"91","author":"I Buchmann","year":"2001","unstructured":"Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al. 2-(Fluorine-18)fluoro- 2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer. 2001;91:889\u201399.","journal-title":"Cancer"},{"key":"4155_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1148\/radiology.203.3.9169707","volume":"203","author":"F Moog","year":"1997","unstructured":"Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology. 1997;203:795\u2013800.","journal-title":"Radiology"},{"key":"4155_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non- Hodgkin\u2019s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol. 2001;19:414\u20139.","journal-title":"J Clin Oncol"},{"key":"4155_CR21","first-page":"601","volume":"42","author":"M Tatsumi","year":"2001","unstructured":"Tatsumi M, Kitayama H, Sugahara H, Tokita N, Nakamura H, Kanakura Y, et al. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin\u2019s lymphoma. J Nucl Med. 2001;42:601\u20138.","journal-title":"J Nucl Med"},{"key":"4155_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1200\/JCO.1988.6.6.931","volume":"6","author":"GP Canellos","year":"1988","unstructured":"Canellos GP. Residual mass in lymphoma may not be residual disease. J Clin Oncol. 1988;6:931\u20133.","journal-title":"J Clin Oncol"},{"key":"4155_CR23","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1200\/JCO.1993.11.11.2273","volume":"11","author":"M Hill","year":"1993","unstructured":"Hill M, Cunningham D, MacVicar D, Roldan A, Husband J, McCready R, et al. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol. 1993;11:2273\u20138.","journal-title":"J Clin Oncol"},{"key":"4155_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ejca.2008.02.005","volume":"44","author":"A Shankar","year":"2008","unstructured":"Shankar A, Fiumara F, Pinkerton R. Role of FDG PET in the management of childhood lymphomas \u2013 case proven or is the jury still out? Eur J Cancer. 2008;44:663\u201373.","journal-title":"Eur J Cancer"},{"key":"4155_CR25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/annonc\/mdi271","volume":"16","author":"MJ Reinhardt","year":"2005","unstructured":"Reinhardt MJ, Herkel C, Altehoefer C, Finke J, Moser E. Computer tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma patients: when do we really need FDG-PET? Ann Oncol. 2005;16:1524\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"4155_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26278","volume":"64","author":"CL Schwartz","year":"2017","unstructured":"Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, et al. Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2017;64(4):10.1002\/pbc.26278.","journal-title":"Pediatr Blood Cancer"},{"key":"4155_CR27","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1182\/blood.V98.10.2930","volume":"98","author":"MR Weihrauch","year":"2001","unstructured":"Weihrauch MR, Re D, Scheidhauer K, Ans\u00e9n S, Dietlein M, Bischoff S, et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood. 2001;98:2930\u20134.","journal-title":"Blood"},{"key":"4155_CR28","unstructured":"Burnelli R, Rinieri S, Todesco A, Locatelli F, Sala A, BuffardiS, et al. Protocollo AIEOP-LH 2004 per la terapia del linfoma di Hodgkin in et\u00e0 pediatrica: analisi ad interim. XXXV Congresso Nazionale AIEOP, Ancona, 26\u201328 October 2008. Aric\u00f3 M, editor. Abstract book, P044. Haematologica 2008;93 Suppl 4:S27."},{"issue":"9","key":"4155_CR29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00259-011-1836-7","volume":"38","author":"E Lopci","year":"2011","unstructured":"Lopci E, Burnelli R, Guerra L, Cistaro A, Piccardo A, Zucchetta P, et al. Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38(9):1620\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4155_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4155_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25(5):571\u20138.","journal-title":"J Clin Oncol"},{"key":"4155_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 1958;53:456\u201381.","journal-title":"J Am Stat Assoc"},{"key":"4155_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables (with discussion). J R Stat Soc Ser B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc Ser B"},{"key":"4155_CR34","first-page":"99","volume":"9","author":"R Sarrazin","year":"1992","unstructured":"Sarrazin R, Dyon JF. Mediastinoscopy. Rev Mal Respir. 1992;9:99\u2013110.","journal-title":"Rev Mal Respir"},{"issue":"1","key":"4155_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.12715","volume":"165","author":"Y Oki","year":"2014","unstructured":"Oki Y, Chuang H, Chasen B, Jessop A, Pan T, Fanale M, et al. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol. 2014;165(1):112\u20136.","journal-title":"Br J Haematol"},{"key":"4155_CR36","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, et al. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: A report from a joint Italian-Danish study. J Clin Oncol. 2007;25:3746\u201352.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4155-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4155-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4155-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T10:50:08Z","timestamp":1720608608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4155-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4155"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4155-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in the AIEOP-LH 2004 protocol involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}